BMJ
Royal_College_calls_for_review_of_bevacizumab_to_treat_AMD_191114
Feb 08
2015
Professor Carrie MacEwen and Professor Andrew Lotery co-author the editorial ‘What is stopping the NHS from using bevacizumab for macular degeneration and other retinal disorders?’, published online on BMJ, calls for UK regulatory bodies to review and appraise use of bevacizumab for use in AMD treatment.